IL6 and Myocardial fibrosis: During this process, inflammatory mediators such as C-reactive protein and interleukin-6 are continuously activated, leading to myocardial cell damage, restricted myocardial energy metabolism, and inhibition of functional recovery through the induction of myocardial fibrosis (13).